Last quarter (Q4 2023), Takeda Pharmaceutical Company's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Takeda Pharmaceutical Company's net income was $―. See Takeda Pharmaceutical Company’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Total Revenue	$ 2.10T	$ 4.26T	$ 4.03T	$ 3.57T	$ 3.20T	$ 3.29T
Cost of Revenue	$ 641.42B	$ 1.43T	$ 1.24T	$ 1.11T	$ 994.31B	$ 1.09T
Gross Profit	$ 1.46T	$ 2.84T	$ 2.78T	$ 2.46T	$ 2.20T	$ 2.20T
Operating Expense	$ 1.21T	$ 2.54T	$ 2.32T	$ 2.21T	$ 1.87T	$ 1.93T
Operating Income	$ 251.43B	$ 298.50B	$ 295.38B	$ 251.12B	$ 338.31B	$ 274.71B
Net Non Operating Interest Income Expense	$ -77.09B	$ -206.68B	$ 62.91B	$ 23.70B	$ -137.85B	$ -146.65B
Other Income Expense	$ -2.64B	$ -11.28B	$ -333.81B	$ -27.76B	$ 165.77B	$ -188.81B
Pretax Income	$ 171.70B	$ 52.79B	$ 692.11B	$ 532.63B	$ 366.24B	$ -60.75B
Tax Provision	$ -9.18B	$ -91.41B	$ 58.05B	$ 72.41B	$ -9.94B	$ -105.04B
Earnings From Equity Interest Net Of Tax	$ ―	$ 6.47B	$ -8.63B	$ -15.37B	$ ―	$ ―
Net Income Common Stockholders	$ 180.87B	$ 144.07B	$ 317.02B	$ 460.33B	$ 376.00B	$ 44.24B
Basic EPS	$ 58.19	$ 92.09	$ 204.29	$ 147.14	$ 120.36	$ 14.21
Diluted EPS	$ 57.55	$ 91.16	$ 201.94	$ 145.87	$ 119.48	$ 14.13
Basic Average Shares	$ 6.25B	$ 1.56B	$ 1.55B	$ 1.56B	$ 3.12B	$ 3.13B
Diluted Average Shares	$ 6.29B	$ 1.58B	$ 1.55B	$ 1.56B	$ 3.15B	$ 3.13B
Dividend Per Share	-	$ 0.94	$ ―	$ ―	$ 90.35	$ 89.67
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ 210.00	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 1.85T	$ 3.97T	$ 3.73T	$ 3.32T	$ 2.86T	$ 3.02T
Net Income From Continuing And Discontinued Operation	$ 180.87B	$ 144.07B	$ 317.02B	$ 460.33B	$ 376.00B	$ 44.24B
Normalized Income	$ 180.87B	$ 36.45B	$ ―	$ ―	$ 261.05B	$ 158.60B
Interest Expense	$ 133.55B	$ ―	$ ―	$ ―	$ 130.81B	$ 149.01B
EBIT	$ 305.25B	$ 206.42B	$ 492.06B	$ 410.20B	$ 497.04B	$ 88.26B
EBITDA	$ 649.96B	$ 934.43B	$ 1.16T	$ 993.35B	$ 1.06T	$ 671.90B

Currency in USD

Takeda Pharmaceutical Company Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing